Day: July 29, 2021

BEIJING, July 29, 2021 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will work with Guizhou Province’s Dafang County authorities to lead the “Early Screening for Regional Liver Cancer Prevention and Containment Demonstration Project”. Backed by the Central Committee of the Chinese Peasants and Workers Democratic Party and guided by China’s National Cancer Center, this project is a collective effort that will be carried out by the Dafang County Health Bureau, the People’s Hospital of Dafang, and Genetron Health. The project seeks to push boundaries for leading cancer early screening...

Bids, sales, stop-rates and prices are presented in the table below:      ISIN Bid Mill. kr. (nominal) Sale Stop-rate (per cent) Pro-rata Price98 18262 DKT 01/09/21 III 2,000 1,000 -0.538 100 % 100.044998 18346 DKT 01/12/21 IV 360 360 -0.54 100 % 100.181898 18429 DKT 01/03/22 I 3,240 1,540 -0.566 100 % 100.332898 18502 DKT 01/06/22 II 5,100 1,100 -0.566 100 % 100.4787Total 10,700 4,000      The sale will settle 2 August 2021.

Correction: AB Klaipedos nafta interim financial information for the 6 months of 2021 has been released on 29 July 2021. AB Klaipėdos nafta (further – KN) informs that it plans to release financial information in 2021 according to the following schedule:Date Reporting informationWithin first 5 working days of every month of 2021 KN preliminary revenues for the previous month29 January 2021 Interim financial information for the year 20207 April 2021 Audited financial statements for the year 202030 April 2021 Interim financial information for the 1st quarter of 20218 June 2021 Social responsibility report for the year 202029 July 2021 Interim financial information for the 6 months of 202129 October 2021 Interim financial information for the 3 quarters of 2021On 30 April 2021, the Company plans to convene an Ordinary...

LONDON, July 29, 2021 (GLOBE NEWSWIRE) — Global investment in the InsurTech sector reached an emphatic record during H1, 2021, as half-year funding of US$7.4 billion exceeded full-year investment in 2020, and in every other year, according to the new Quarterly InsurTech Briefing from Willis Towers Watson, a leading global advisory, broking and solutions company (NASDAQ: WLTW). The latest quarter saw 162 deals yield more than $4,824 million in investment, a 210% increase over Q2, 2020. The enormous quarterly total, itself more than any annual total before 2019, was driven largely by 15 mega-rounds of $100 million or more. Collectively, these deals reached $3.3 billion, or two-thirds of total funding during the quarter. The money was raised predominantly by later-stage players seeking expansion. Meanwhile Series B and C fundraisings...

The following resolutions have been adopted at the Extraordinary General Meeting of Shareholders of Panevezio statybos trestas AB held on 29 July 2021: 1. Selection of an audit company and pricing of audit services. 1.1. To select Grant Thornton UAB as an auditor to carry out the audit of the financial statement sets of Panevezio statybos trestas AB and the companies of Panevezio statybos trestas AB Group for the years 2021 and 2022. To pay the amount not exceeding 65,000 (sixty five thousand) Euros (VAT excluded) per one year for the audit of the financial statement sets of all companies of Panevezio statybos trestas AB Group located in Lithuania, which are subject to the audit in the years 2021 and 2022 (Panevezio statybos trestas AB, Metalo meistrai UAB, Vekada UAB, Skydmedis UAB), for the audit of the financial statement sets for the...

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into a collaboration with Oxford University in the United Kingdom (UK) to provide TPOXX® (tecovirimat) under an expanded access protocol to treat individuals affected by monkeypox in the Central African Republic (CAR). Under the agreement, Oxford University will sponsor the protocol and study in CAR, and SIGA will provide up to 500 courses of TPOXX (tecovirimat) at no cost. The Institut Pasteur of Bangui (“IPB”), a research foundation established in CAR in 1961, will act as coordinator and be responsible for oversight and conduct of the study in CAR including managing the investigational sites, hosting the clinical trial database...

ABERDEEN, United Kingdom, July 29, 2021 (GLOBE NEWSWIRE) — Altera Infrastructure GP LLC, the general partner of Altera Infrastructure L.P. (“Altera” or the “Partnership”), today announced that Altera Infrastructure Holdings L.L.C. (“Holdings”), a wholly owned subsidiary of the Partnership, has commenced an offer (the “Exchange Offer”) to each Eligible Holder of the 8.50% Senior Notes due 2023 (the “Old Notes”) issued by the Partnership and Altera Infrastructure Finance Corp. (“Finco” and, together with the Partnership, the “Old Notes Issuers”) upon the terms and subject to the conditions set forth in the confidential offering memorandum and consent solicitation statement, dated July 29, 2021 (the “Offering Memorandum”) to participate in the options below at the election of such Eligible Holders:Option 1: Offer to Eligible Holders...

FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY   1.        KEY INFORMATION  (a)        Name of exempt principal trader:Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeGood Energy Group plc(c)        Name of the party to the offer with which exempt principal trader is connected:Investec is Joint advisor to Good Energy Group plcd)        Date dealing undertaken:28th July 2021(e)        Has the EPT previously disclosed, or is it today disclosing, in respect of any other party to this offer? No  2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER   (a)        Purchases and sales  Class...